PLC-β2 activity on actin-associated polyphosphoinositides promotes migration of differentiating tumoral myeloid precursors

Federica Brugnoli, Alberto Bavelloni, Mascia Benedusi, Silvano Capitani, Valeria Bertagnolo

Research output: Contribution to journalArticlepeer-review

Abstract

During both maturation and function, neutrophils are subjected to reorganization of the actin cytoskeleton. Among the molecules that influence cytoskeletal architecture, the amount and subcellular localization of phosphoinositides, regulated by specific kinases and phosphatases, may play a crucial role. In neutrophils, PLC-β2 is a major phosphoinositide-dependent phospholipase C isoform activated in response to chemoattractants, even though its role in the modifications of cell morphology and motility that occur during the inflammatory process has not been fully elucidated. In APL-derived promyelocytes induced to complete their maturation program, we have found that the expression levels of PLC-β2 positively correlate with the degree of the reached neutrophil differentiation. Here, we demonstrate that PLC-β2 modulates the migration capability of promyelocytes induced to differentiate with ATRA. In differentiating cells, the association of PLC-β2 with actin, mediated by the PH domain, seems crucial for catalytic activity. We conclude that phosphodiesterase activity of PLC-β2 on the actin-associated PIP2 may be responsible, by modifying the phosphoinositide pools, for the modifications of cytoskeleton architecture that take place during motility of differentiating promyelocytes.

Original languageEnglish
Pages (from-to)1701-1712
Number of pages12
JournalCellular Signalling
Volume19
Issue number8
DOIs
Publication statusPublished - Aug 2007

Keywords

  • Actin
  • Acute promyelocytic leukemia (APL)
  • NB4
  • Phosphoinositide metabolism
  • PLC-β2

ASJC Scopus subject areas

  • Cell Biology

Fingerprint

Dive into the research topics of 'PLC-β2 activity on actin-associated polyphosphoinositides promotes migration of differentiating tumoral myeloid precursors'. Together they form a unique fingerprint.

Cite this